Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

• Status: RECRUITING
• Trial end date: 2029-11-01

Summary

To evaluate the efficacy and safety of bendamustine combined with chidamide and lenalidomide in R/R PTCL patients.

• Phase: NA

Details

• Lead Sponsor: The First Affiliated Hospital of Soochow University